- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Phenergan ( Promethazine )
Phenergan (promethazine hydrochloride) is a first‑generation phenothiazine antihistamine with anticholinergic, antiemetic, sedative, and antiserotonergic properties. It is indicated for the symptomatic relief of allergic conditions (such as rhinitis and urticaria), for the prevention and treatment of nausea and vomiting including motion sickness, and as a pre‑ or postoperative sedative or adjunct to analgesia. Promethazine works by blocking H1 histamine receptors, dopamine D2 receptors, and muscarinic cholinergic receptors, producing antihistaminic, antiemetic, and sedative effects. It is available only by prescription in Canada.
Usual adult dose: For allergic conditions, the usual dose is 25 mg taken orally at bedtime, or 10 mg to 25 mg three to four times daily as needed. For motion sickness, 25 mg should be taken 30 to 60 minutes before travel and may be repeated every 8 to 12 hours as needed. For nausea and vomiting, 25 mg is given every 4 to 6 hours as required. For pre‑ or postoperative sedation, 25 mg to 50 mg may be given as a single dose. The 10 mg tablet is used for lower‑dose regimens or for patients who are sensitive to sedative effects; the 25 mg tablet is the standard adult strength. The maximum recommended daily dose is generally 50 mg to 100 mg depending on the indication and patient tolerance; doses should not exceed 100 mg per day in most ambulatory settings. Promethazine should be taken with food or milk to reduce gastrointestinal upset. If a dose is missed, it should be taken as soon as remembered, but two doses should not be taken at the same time. In elderly patients, lower doses should be used and the drug should be avoided if possible due to the risk of confusion, sedation, and anticholinergic effects. Promethazine is contraindicated in children under 2 years of age because of the risk of fatal respiratory depression.
Dosage form: Oral tablets: 10 mg (white to off‑white, round, scored) and 25 mg (white to off‑white, round, scored). Also available as a rectal suppository (12.5 mg, 25 mg, 50 mg) and as an injectable solution (25 mg/mL) for intramuscular or intravenous use in clinical settings. The 25 mg tablet is the most commonly used oral strength for adults.
Onset of action: Antihistaminic and antiemetic effects begin within 20 to 40 minutes after oral administration, with peak plasma concentrations at 2 to 3 hours. Sedative effects are usually noticeable within 30 to 60 minutes. For motion sickness, the medication should be taken at least 30 minutes before travel to be effective.
Duration of action: The clinical effect lasts approximately 4 to 6 hours, although the elimination half‑life is longer (approximately 10 to 14 hours). Dosing three to four times daily or at bedtime provides adequate symptom control. The sedative effect may persist longer than the antihistaminic effect, causing residual drowsiness the following morning.
Alcohol recommendation: Alcohol must be avoided during promethazine therapy. Alcohol significantly potentiates the central nervous system depressant effects of promethazine, including sedation, dizziness, confusion, and respiratory depression. The combination can impair psychomotor function and increase the risk of accidental injury. Patients should not drive or operate hazardous machinery while taking this medication.
Most common side effects: Drowsiness, dizziness, dry mouth, blurred vision, constipation, and urinary retention. Drowsiness is very common and may diminish with continued use but should always be anticipated. Anticholinergic effects such as dry mouth and constipation can be managed with hydration and dietary fibre. Extrapyramidal symptoms, including dystonia, akathisia, and tardive dyskinesia, may occur, particularly at higher doses or with prolonged use. Neuroleptic malignant syndrome is a rare but life‑threatening reaction characterized by hyperthermia, muscle rigidity, and autonomic instability. Promethazine is contraindicated in patients with known hypersensitivity to phenothiazines, in comatose patients, and in children under 2 years. It should be used with caution in patients with asthma, sleep apnea, narrow‑angle glaucoma, prostatic hypertrophy, seizure disorders, or hepatic impairment. Respiratory depression has been reported even at usual doses in vulnerable populations; the lowest effective dose should be used. In Canada, Phenergan is available only by prescription and must be prescribed and monitored by a healthcare professional.
Would you like to try Phenergan (Promethazine) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
